Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Vivanza Biosciences Ltd Stock Analysis

Small Cap
Evaluated by 25 users | BSE: 530057 | NSE: |
Trading

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Capital Employed -0.04%-9.1%-88.21%-8.66%-8.4%-10.26%-6.01%11.21%-3.41%2.68%12.37%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 0000003.56.42.29.49.29
Y-o-Y Gr. Rt.-NANANANANANA85.6%-65.5%324.8%-2.2%-
Adjusted EPS (Rs.) 0-1.51-3.37-0.14-0.14-3.21-0.430.6-1.12-0.510.251.60
Y-o-Y Gr. Rt.-NANANANANANANA-286.7%NANA-
Book Value per Share (Rs.) 5.414.870.620.480.341.329.29.88.678.168.4110.00
Adjusted Net Profit 0-0.6-1.3-0.1-0.1-0.1-0.20.2-0.5-0.20.11
Net Op. Cash Flow (Rs. Cr.) 0-0.3-0.600-0.1-2-0.21.42.8-3.1-
Debt to Cash Flow from Ops 0-1.41-0.61-10.56-10.71-10.88-0.27-4.730.660.06-0.06-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Vivanza Biosciences Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales NANA12.7%-2.2%
Adjusted EPS NANA-25.3%NA
Book Value per Share 6.344.8-53.1
Share Price - 8.5% 98.5% 260.2%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Equity (%) -0.05-28.7-118.2-21.78-27.33-63.16-9.326.32-12.16-6.053.0117.38
Operating Profit Margin (%) 000000-4.639.88-1.28-3.151.442.48
Net Profit Margin (%) 000000-4.973.73-20.21-2.161.087.42
Debt to Equity 0.290.21.532.163.7920.30.140.20.260.050.050
Working Capital Days 0000004185131,865486441316
Cash Conversion Cycle 00000013711497-1313102
Loading price chart...
Entity Percentage Holding
Promoters 47.80%
Non-Institutions 52.20%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Vivanza Biosciences Ltd's earnings have grown by 0%, whereas share price has appreciated 8.5% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.

Data is not available for this company

Data is not available for this company.

Head quartered in Gujarat, Vivanza Biosciences Limited came into existence in April 2016 with the sole aim to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system. It is the bridge between people, Medical Practitioners and the Patients and together it is a healthcare organization dedicated to improving the lives of people globally.

Business

Head quartered in Gujarat, Vivanza Biosciences Limited came into existence in April 2016 with the sole aim to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system. It is the bridge between people, Medical Practitioners and the Patients and together it is a healthcare organization dedicated to improving the lives of people globally.

Business area of the company

The company is engaged in the business of business of Pharmaceutical Products.

Products

  • Gloves
  • Surgicals
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
© 2021 MoneyWorks4me.com | All Rights Reserved